Results 161 to 167 of about 588,781 (167)

Postmarketing surveillance of serious adverse events associated with the use of rofecoxib from 1999–2002

Current Medical Research and Opinion, 2009
Frank G Bottone
exaly  

Policosanol: results of a postmarketing surveillance study of 27,879 patients

Current Therapeutic Research, 1998
Julio Cesar Fernandez Travieso, Lilia Fernández, Rosa Mas   +2 more
exaly  

Efficacy and safety of garenoxacin tablets on clinically diagnosed atypical pneumonia: Postmarketing surveillance in Japan

Journal of Infection and Chemotherapy, 2014
Tadashi Ishida, Koichi Izumikawa, Naoyuki Miyashita   +2 more
exaly  

Postmarketing Surveillance: Lessons Learned

Drug Information Journal, 1991
Gerald A Faich
exaly  

Safety and efficacy of mogamulizumab in patients with adult T-cell leukemia–lymphoma in Japan: interim results of postmarketing all-case surveillance

International Journal of Hematology, 2017
Takeshi Takahashi, Kenji Ishitsuka
exaly  

Assessment Methodologies in Nonexperimental Postmarketing Surveillance

2008
Todd A Durham
exaly  

Assessing risk in postmarketing surveillance

Journal of Biopharmaceutical Statistics, 1991
exaly